Comparison of PET/CT vs. PET/MRI Using 2 Radiopharmaceuticals

Not Recruiting

Trial ID: NCT03125629

Age - 18 Years-N/A Gender - All Accepting Healthy Volunteers - No

Purpose

This clinical trial studies how well positron emission tomography (PET)/computed tomography (CT) works compared to PET/magnetic resonance imaging (MRI) in evaluating patients with cancer. PET/CT and PET/MRI may determine which scanner is best for the patient's type of cancer and other types of cancers.

Official Title

Comparison of PET/CT vs. PET/MRI

Stanford Investigator(s)

Andrei Iagaru
Andrei Iagaru

Professor of Radiology (Nuclear Medicine)

Eligibility


INCLUSION CRITERIA

   - Cancer diagnosis

   - Capable of complying with study procedures

   - Able to remain still for duration of imaging procedure (approximately 90 minutes
   total)

   - Written informed consent

EXCLUSION CRITERIA

   - Pregnant or nursing

   - Metallic implants

   - Impaired renal function

View More
View Less

Intervention(s):

drug: Ga-68-DOTA-TATE

drug: F-18 FDG

device: Positron Emission Tomography / Computed Tomography (PET/CT) Scan

device: Positron Emission Tomography / Magnetic Resonance Imaging (PET/MRI) Scan

Not Recruiting

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305

©2024 Stanford Medicine